Consolidations continue to transform the roster of largest medical device companies in the world — as evidenced by the latest Big 100 list at our sister site Medical Design & Outsourcing. Overall, Big 100 companies saw $397.5 billion in sales during their most recent fiscal years, up 3.5% from the previous year. As companies continue to […]
Functional Neuromodulation launches Alzheimer’s DBS trial
Functional Neuromodulation said yesterday that it has begun a pivotal clinical trial to assess deep brain stimulation (DBS) in patients with mild Alzheimer’s disease. The Minneapolis-based company said the study will evaluate the safety and efficacy of stimulating the fornix (DBS-f) — a major inflow and output pathway in the brain’s memory circuit. Research suggests […]
Boston Scientific warns on battery risk with some older Emblem S-ICDs
A small group of older Boston Scientific (NYSE:BSX) subcutaneous implantable cardioverter defibrillators have an increased risk of early battery depletion, the company said this month in an advisory letter to physicians. The Marlborough, Mass.-based company said the issue affects about 400 (0.7%) of its Emblem S-ICD and Emblem MRI S-ICD devices. Those devices have “an elevated […]
Varian closes $90m microspheres buy from Boston Scientific
Hot on the heels of the $4 billion buyout of BTG by Boston Scientific (NYSE:BSX), Varian (NYSE:VAR) said yesterday that it closed the $90 million acquisition of Boston’s microspheres business. The deal for the drug-eluting and “bland” embolic microsphere business, which includes the Oncozene, Embozene and Embozone Tandem products, was struck to mollify anti-trust regulators about the BTG […]
Study: No difference between Biotronik, Medtronic or Boston Scientific stents
A study comparing drug-eluting stents made by Biotronik, Medtronic (NYSE:MDT) and Boston Scientific (NYSE:BSX) found no statistically significant difference on target vessel failure or stent thrombosis after three years. The 3,514-patient Bio-Resort trial compared Biotronik’s Orsiro biodegradable sirolimus-eluting stent, Medtronic’s thin-strut zotarolimus-eluting Resolute Integrity stent and the Synergy biodegradable everolimus-eluting stent. Get the full story at […]
Boston Scientific wins FDA nod for MR-safe Vercise Gevia DBS
Boston Scientific (NYSE:BSX) said yesterday that it won FDA approval for MR-conditional labeling on its Vercise Gevia deep-brain stimulation device for treating Parkinson’s disease. The ImageReady MRI label means the device and its companion Vercise Cartesia directional lead can be used during 1.5-Tesla full-body MRI scans, the Marlborough, Mass.-based company said. “Boston Scientific continually strives to […]
Boston Scientific closes $4B BTG purchase
Boston Scientific (NYSE:BSX) said today that it finished its $4 billion acquisition of BTG (LN:BTG). The Marlborough, Mass.-based medtech giant reported that the transaction will be immaterial to adjusted earnings per share this year, thanks to – among other factors – the deal closing later than initially anticipated. To satisfy antitrust regulators, Boston Scientific is […]
UK regulators OK Boston Scientific’s $4B BTG buyout
British regulators have approved Boston Scientific’s (NYSE:BSX) $4 billion bid to buy BTG (LN:BTG), the companies announced today in regulatory filings. The deal, approved by the U.S. Federal Trade Commission on August 7, will close on Monday. The High Court of Justice in England and Wales agreed to the takeover following a hearing today. Boston […]
New building on the way for innovation campus near Mayo Clinic
Developer M.A. Mortenson Co. has filed plans for a five-story, 121,295-square-foot Two Discovery Square — the second building for the innovation campus next to Mayo Clinic in Rochester, Minn., the Rochester Post Bulletin reports. Mortenson and the Destination Medical Center project office didn’t provide additional details to the newspaper. The original roughly 90,000-square-foot One Discovery […]
FTC clears Boston Sci’s $4B purchase of BTG
The Federal Trade Commission has approved Boston Scientific’s $4 billion acquisition of British medtech company BTG (LON:BTG), according to a regulatory filing. Other antitrust authorities, such as the Federal Competition Authority of Austria and the National Authority for Markets and Competition in Spain, cleared the takeover in the past few weeks, according to the filing. […]
Medicare might cover more cutting-edge medtech and pay more for it, too
The Centers for Medicare and Medicaid Services (CMS) said today it wants to give Medicare patients better access to cutting-edge medical devices, and that it’s willing to pay more for them beginning in fiscal year 2020. In its proposed rule, CMS said it might pay more for “certain transformative new devices” for inpatients through a […]
- 1
- 2
- 3
- …
- 140
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube